NCT03865888 Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome Status COMPLETED Phase PHASE3
NCT03856216 Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation Status TERMINATED Phase PHASE2
NCT03816332 Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03794492 Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome Status COMPLETED Phase PHASE4
NCT03779854 Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant Status RECRUITING Phase PHASE2
NCT03770663 Cyclophosphamide and Azathioprine vs Tacrolimus in Antisynthetase Syndrome-related Interstitial Lung Disease Status UNKNOWN Phase PHASE3
NCT03760263 Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus Status COMPLETED Phase PHASE4
NCT03751332 The Vienna Prograf and Endothelial Progenitor Cell Extension Study Status COMPLETED Phase PHASE4
NCT03737708 A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE4
NCT03734601 Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation Status COMPLETED Phase PHASE2
NCT03712878 2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies Status COMPLETED Phase PHASE2
NCT03703154 Alterations in Cognitive Function and Cerebral Blood Flow After Conversion From Immediate Release Tacrolimus to Slow Release Envarsus Status COMPLETED Phase N/A
NCT03699631 PROACTIVE: Preventing Acute/Chronic GVHD With TocIlizumab Combined With GVHD Prophylaxis Post allogEneic Transplant Status COMPLETED Phase PHASE2
NCT03680092 Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation Status COMPLETED Phase PHASE2
NCT03670966 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome Status RECRUITING Phase PHASE1/PHASE2